IDRA Idera Pharmaceuticals Inc

Idera Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in the discovery, development and commercialization of novel therapeutics for oncology and rare diseases.

$0.32
As of 12/02/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/14/2001
Outstanding shares:  53,050,069
Average volume:  93,711
Market cap:   $16,710,772
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.66
PS ratio:   0.00
Return on equity:   -84.45%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy